Salt Lake City, UT, United States of America

Charles D Ebert

USPTO Granted Patents = 44 (Patent Applications = 2)

CIPO Patents = 6

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 26

Forward Citations = 2,724(Granted Patents)

Location History:

Redwood City, CA (US) (1990)
Salt Lake City, UT (US) (1989 - 2019)

Company Filing History:

Watson Laboratories Inc.

patents

5 out of 27

Watson Pharmaceuticals, Inc.

patents

4. 4 out of 6,850

Ciba-geigy Corporation

Stanley Research Foundation

where one patent can have more than one assignee

Years Active: 1989-2019

Loading Chart...

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10500215 - Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith (2019-12-10),

2. 10272061 - Compositions and methods for unoccluded transdermal oxybutynin therapy (2019-04-30),

3. 10137135 - Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith (2018-11-27),

4. 8241662 - Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy (2012-08-14),

5. 7179483 - Compositions and methods for transdermal oxybutynin therapy (2007-02-20),

6. 7087241 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2006-08-08),

7. 7081252 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2006-07-25),

8. 7081251 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2006-07-25),

9. 7081250 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2006-07-25),

10. 7081249 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2006-07-25),

11. 7029694 - Compositions and methods for transdermal oxybutynin therapy (2006-04-18),

12. 6743441 - Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy (2004-06-01),

13. 6730318 - Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties (2004-05-04),

14. 6365178 - Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions (2002-04-02),

15. 6180133 - Antioxidant composition for topical/transdermal prevention and treatment of wrinkles (2001-01-30),

Title: The Legacy of Charles D Ebert: Pioneering Inventor from Salt Lake City

Introduction: Charles D Ebert is a distinguished inventor hailing from the vibrant city of Salt Lake City, UT. His innovative spirit and dedication to technological advancement have left a lasting impact on the world of patents and inventions.

Latest Patents: Charles D Ebert's latest patents showcase his forward-thinking approach to problem-solving and creativity. His recent inventions have revolutionized industries such as renewable energy, healthcare, and consumer electronics.

Career Highlights: Throughout his illustrious career, Charles D Ebert has been recognized for his groundbreaking inventions and contributions to the field of technology. His work has earned him numerous accolades and awards, solidifying his reputation as a visionary inventor.

Collaborations: Charles D Ebert has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in turning his innovative ideas into tangible products that benefit society as a whole.

Conclusion: In conclusion, Charles D Ebert's passion for innovation and relentless pursuit of excellence have established him as a trailblazing inventor in Salt Lake City and beyond. His remarkable contributions to the world of patents continue to inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.